US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 9.2300
  • +0.4400+5.01%
Close Sep 27 16:00 ET
  • 9.2300
  • 0.00000.00%
Post 20:02 ET
97.43MMarket Cap-1675P/E (TTM)

Benitec Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Total revenue
0
0
0
0
0
2.74%75K
7K
12.50%54K
-44.00%14K
0
Operating revenue
--0
--0
--0
--0
--0
2.74%75K
--7K
12.50%54K
-44.00%14K
--0
Cost of revenue
1K
0
Gross profit
-107.14%-1K
14K
Operating expense
17.40%22.49M
21.75%5.55M
-5.78%4.14M
23.15%6.93M
28.25%5.87M
6.91%19.16M
-3.64%4.56M
25.29%4.4M
15.72%5.62M
-5.02%4.58M
Selling and administrative expenses
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
-5.97%1.92M
-General and administrative expense
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
-5.97%1.92M
Research and development costs
22.19%15.61M
10.23%3.51M
-18.98%2.57M
35.66%5.1M
66.50%4.43M
13.33%12.77M
0.31%3.19M
45.88%3.17M
19.55%3.76M
-4.32%2.66M
Other operating expenses
---108K
--0
---3K
----
---106K
----
----
----
----
----
Operating profit
-17.87%-22.49M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
-28.25%-5.87M
-6.87%-19.08M
3.97%-4.55M
-25.46%-4.34M
-16.03%-5.61M
5.02%-4.58M
Net non-operating interest income expense
2,839.39%904K
11,600.00%920K
42.86%-4K
33.33%-6K
33.33%-6K
-3.13%-33K
20.00%-8K
30.00%-7K
18.18%-9K
-800.00%-9K
Non-operating interest expense
----
----
-42.86%4K
-33.33%6K
-33.33%6K
----
----
-30.00%7K
-18.18%9K
800.00%9K
Total other finance cost
-2,839.39%-904K
----
----
----
----
--33K
----
----
----
----
Other net income (expense)
63.17%-165K
10.68%-92K
-173.47%-134K
-35.10%135K
85.32%-74K
-39.13%-448K
67.71%-103K
-125.13%-49K
732.00%208K
-127.03%-504K
Gain on sale of security
109.33%39K
369.57%62K
-140.82%-118K
-4.43%151K
88.89%-56K
-72.02%-418K
91.45%-23K
-121.88%-49K
532.00%158K
-127.03%-504K
Other non- operating income (expenses)
-580.00%-204K
-92.50%-154K
---16K
-132.00%-16K
---18K
62.03%-30K
-60.00%-80K
----
--50K
----
Income before tax
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
Income tax
Net income
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
Net income continuous Operations
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
Minority interest income
Net income attributable to the parent company
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
Preferred stock dividends
Other preferred stock dividends
619K
0
Net income attributable to common stockholders
-14.35%-22.37M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
-0.95%-5.09M
Basic earnings per share
60.98%-5.51
78.49%-0.57
38.58%-1.64
20.96%-2.64
65.41%-2.76
62.72%-14.12
74.79%-2.65
60.74%-2.67
66.70%-3.34
24.29%-7.98
Diluted earnings per share
60.98%-5.51
78.49%-0.57
38.58%-1.64
20.96%-2.64
65.41%-2.76
62.72%-14.12
74.79%-2.65
60.74%-2.67
66.70%-3.34
24.29%-7.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Total revenue 000002.74%75K7K12.50%54K-44.00%14K0
Operating revenue --0--0--0--0--02.74%75K--7K12.50%54K-44.00%14K--0
Cost of revenue 1K0
Gross profit -107.14%-1K14K
Operating expense 17.40%22.49M21.75%5.55M-5.78%4.14M23.15%6.93M28.25%5.87M6.91%19.16M-3.64%4.56M25.29%4.4M15.72%5.62M-5.02%4.58M
Selling and administrative expenses 9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M-5.97%1.92M
-General and administrative expense 9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M-5.97%1.92M
Research and development costs 22.19%15.61M10.23%3.51M-18.98%2.57M35.66%5.1M66.50%4.43M13.33%12.77M0.31%3.19M45.88%3.17M19.55%3.76M-4.32%2.66M
Other operating expenses ---108K--0---3K-------106K--------------------
Operating profit -17.87%-22.49M-21.93%-5.55M4.61%-4.14M-23.48%-6.93M-28.25%-5.87M-6.87%-19.08M3.97%-4.55M-25.46%-4.34M-16.03%-5.61M5.02%-4.58M
Net non-operating interest income expense 2,839.39%904K11,600.00%920K42.86%-4K33.33%-6K33.33%-6K-3.13%-33K20.00%-8K30.00%-7K18.18%-9K-800.00%-9K
Non-operating interest expense ---------42.86%4K-33.33%6K-33.33%6K---------30.00%7K-18.18%9K800.00%9K
Total other finance cost -2,839.39%-904K------------------33K----------------
Other net income (expense) 63.17%-165K10.68%-92K-173.47%-134K-35.10%135K85.32%-74K-39.13%-448K67.71%-103K-125.13%-49K732.00%208K-127.03%-504K
Gain on sale of security 109.33%39K369.57%62K-140.82%-118K-4.43%151K88.89%-56K-72.02%-418K91.45%-23K-121.88%-49K532.00%158K-127.03%-504K
Other non- operating income (expenses) -580.00%-204K-92.50%-154K---16K-132.00%-16K---18K62.03%-30K-60.00%-80K------50K----
Income before tax -11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M
Income tax
Net income -11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M
Net income continuous Operations -11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M
Minority interest income
Net income attributable to the parent company -11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M
Preferred stock dividends
Other preferred stock dividends 619K0
Net income attributable to common stockholders -14.35%-22.37M-14.55%-5.34M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M-0.95%-5.09M
Basic earnings per share 60.98%-5.5178.49%-0.5738.58%-1.6420.96%-2.6465.41%-2.7662.72%-14.1274.79%-2.6560.74%-2.6766.70%-3.3424.29%-7.98
Diluted earnings per share 60.98%-5.5178.49%-0.5738.58%-1.6420.96%-2.6465.41%-2.7662.72%-14.1274.79%-2.6560.74%-2.6766.70%-3.3424.29%-7.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data